|
Company
|
||||||
|---|---|---|---|---|---|---|
|
Roivant Sciences Ltd
ROIV
|
NASDAQ
|
USA
|
Healthcare
|
19.58
$
|
2.09
%
|
9.83B
$
|
|
Exelixis
EXEL
|
NASDAQ
|
USA
|
Healthcare
|
38.67
$
|
-0.69
%
|
9.86B
$
|
|
Vaxcyte Inc
PCVX
|
NASDAQ
|
USA
|
Healthcare
|
44.75
$
|
1.18
%
|
9.99B
$
|
|
Exact Sciences
EXAS
|
NASDAQ
|
USA
|
Healthcare
|
63.22
$
|
2.33
%
|
10.35B
$
|
|
Insmed
INSM
|
NASDAQ
|
USA
|
Healthcare
|
194.22
$
|
-2.38
%
|
11.33B
$
|
|
Summit Therapeutics
SMMT
|
NASDAQ
|
UK
|
Healthcare
|
18.91
$
|
1.45
%
|
12.82B
$
|
|
BioMarin Pharmaceutical
BMRN
|
NASDAQ
|
USA
|
Healthcare
|
51.91
$
|
3.2
%
|
12.93B
$
|
|
Sarepta Therapeutics
SRPT
|
NASDAQ
|
USA
|
Healthcare
|
23.25
$
|
3.27
%
|
13.12B
$
|
|
Genmab AS
GMAB
|
NASDAQ
|
USA
|
Healthcare
|
28.67
$
|
-0.21
%
|
13.49B
$
|
|
Neurocrine Biosciences
NBIX
|
NASDAQ
|
USA
|
Healthcare
|
138.04
$
|
3.75
%
|
14.16B
$
|
|
Incyte
INCY
|
NASDAQ
|
USA
|
Healthcare
|
92.59
$
|
0.96
%
|
14.54B
$
|
|
Royalty Pharma Plc
RPRX
|
NASDAQ
|
USA
|
Healthcare
|
36.95
$
|
1.6
%
|
15.12B
$
|
|
Moderna
MRNA
|
NASDAQ
|
USA
|
Healthcare
|
27.16
$
|
-3.48
%
|
15.97B
$
|
|
Avacta Group PLC
AVCT
|
LSE
|
UK
|
Healthcare
|
70
£
|
2.94
%
|
16.35B
£
|
|
United Therapeutics
UTHR
|
NASDAQ
|
USA
|
Healthcare
|
453.53
$
|
-1.79
%
|
17.11B
$
|
|
Artgen
ABIO
|
MOEX
|
Russia
|
Healthcare
|
66.16
₽
|
-0.7
%
|
17.41B
₽
|
|
4BASEBIO UK SOCIETAS
4BB
|
LSE
|
UK
|
Healthcare
|
790
£
|
-
|
18.72B
£
|
|
BeiGene, Ltd.
ONC
|
NASDAQ
|
USA
|
Healthcare
|
310.48
$
|
0.73
%
|
19.45B
$
|
|
Natera
NTRA
|
NASDAQ
|
USA
|
Healthcare
|
193.22
$
|
2.96
%
|
19.74B
$
|
|
Biogen
BIIB
|
NASDAQ
|
USA
|
Healthcare
|
154.27
$
|
3.11
%
|
22.31B
$
|